Swedish biotech group agrees €577m takeover

Deutsche Bank and its Swedish biotech client, Perbio Science, have accepted a Skr5.3bn (€577m) offer from Fisher Scientific International, the US laboratory equipment maker.

The target recommended the Skr142.5-a-share cash bid to shareholders. It represented a 28% premium to the volume-weighted average price of Perbio's shares over the past 60 trading days and a 14% premium to their previous close.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump